Please provide your email address to receive an email when new articles are posted on . To increase the speed with which new treatments for childhood-onset systemic lupus erythematosus are studied, ...
Response to treatments is highly heterogeneous in cancer. Increased availability of biomarkers and targeted treatments has led to the need for trial designs that efficiently test new treatments in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results